Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital with participation from GV and ...

Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...

The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its ...

AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...

Isomorphic Labs’ financing led the way for first quarter 2025 financings, but it comes amid headwinds for the biotech sector.

Recursion Pharmaceuticals—a relatively small company backed by the chip giant Nvidia—is betting that its massive ...

New center will use cutting-edge AI to accelerate the creation of life-saving medicines AI Small Molecule Drug Discovery ...

While I see generative AI emerging as healthcare’s most transformative disruptor, its full potential relies on robust data ...

AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding ...

We may make money when you click on links to our partners. Learn More. AI drug design and development company Isomorphic Labs announced on Monday that it raised $600 million in its first external ...

The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...

The funding will accelerate further development of Isomorphic’s AI drug design engine and support the company’s goal of bringing its discovered drugs to clinical trials. Isomorphic Labs was ...